Idarubicin Combined to Azacitidine in Int-2 or High Risk Myelodysplastic Syndromes
Clinical trial NCT01305135 · COMPLETED
Trial details
- NCT number
- NCT01305135
- Sponsor
- Groupe Francophone des Myelodysplasies
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-12-30
- Primary completion
- 2011-06-01
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.